Vident Advisory, LLC Ionis Pharmaceuticals Inc Transaction History

Vident Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$42.03 - $53.55 $5,632 - $7,175	-134 Reduced 2.72%	4,796 $208 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $28,463 - $33,869	-656 Reduced 11.74%	4,930 $249 Million
Q3 2023 Feb 21, 2024	BUY	$38.5 - $47.13 $25,256 - $30,917	656 Added 13.31%	5,586 $253 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $215,061 - $263,268	5,586 New	5,586 $253 Million

395

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.38B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.